Status:
UNKNOWN
Narrative Exposure Therapy to Reduce Symptoms of Traumatic Stress in Cancer Survivors
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
National Health Service, United Kingdom
Conditions:
Traumatic Stress Disorder
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main purpose of the study is to evaluate the feasibility, acceptability, and potential effectiveness of NET in reducing symptoms of traumatic stress (e.g., hyperarousal, avoidance, and intrusion) ...
Detailed Description
Research has shown that cancer can lead to significant emotional and social distress. Many elements of the cancer experience can be perceived as traumatic by cancer patients, including diagnostic test...
Eligibility Criteria
Inclusion
- Adults (18 and over)
- Diagnosed with cancer in adulthood
- Able to provide informed consent
- Able to communicate verbally and speak English
- Not in active treatment (at any stage post-treatment)
- Suffer from symptoms of traumatic stress caused or triggered by the cancer experience. A diagnosis of PTSD is not required (PTSD Checklist Civilian, PCL-C cut-off score: 29 and above).
- No specific form of cancer
Exclusion
- Participants have a known diagnosis of Intellectual Disability (ID)
- Participants must not be receiving other forms of psychosocial support whilst engaging in NET
- They are substance dependent
- They are actively psychotic
Key Trial Info
Start Date :
March 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT05272553
Start Date
March 4 2022
End Date
September 1 2023
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Nottingham
Nottingham, Nottinghamshire, United Kingdom, NG8 1BB